サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1678732

性感染症自己検査の世界市場：市場規模・シェア・動向分析 (用途別・地域別)、セグメント別予測 (2025年～2030年)

STD Self-Testing Market Size, Share & Trends Analysis Report By Application (CT/NG Testing, Syphilis Testing, HIV Testing), By Region (North America, Asia Pacific, Europe, Latin America, MEA), And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
性感染症自己検査の世界市場：市場規模・シェア・動向分析 (用途別・地域別)、セグメント別予測 (2025年～2030年)
出版日: 2025年02月17日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

性感染症自己検査市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の性感染症 (STD) 自己検査の市場規模は2030年までに19億8,000万米ドルに達する見込みです。

同市場は2025年から2030年にかけてCAGR 8.75％で拡大すると予測されます。プライバシーと利便性に対する需要の高まりは、性感染症自己検査市場の主要促進要因です。STDにまつわる汚名や守秘義務への懸念から、特に小規模な地域や医療へのアクセスが限られている地域では、クリニックを訪れることをためらう人が多いです。自宅で簡単に検査ができる自己検査キットを使えば、クリニックを受診することなく個人的に検査を受けることができます。オンラインで検査を注文し、迅速で信頼できる結果を受け取るという手軽さが、特に健康管理における自主性と秘密保持を重視する若年層の間で、自己検査ソリューションの採用に大きく寄与しています。個人がより個別化された、手間のかからない医療の選択肢を求めているため、この動向は今後も市場を牽引していくと予想されます。

さらに、性感染症の感染率の増加は、よりアクセスしやすく効率的なソリューションの必要性を強調するものであるため、性感染症自己検査市場を大きく牽引すると予想されます。HIV、クラミジア、梅毒、淋病の症例が世界的に増加する中、公衆衛生システムは早期発見と予防戦略にますます重点を置くようになっています。自己検査キットは実用的な解決策を提供し、個人のプライバシーを守りながら検査を行い、速やかに治療を受けることを可能にします。定期的なSTD検査の重要性に対する意識の高まりと、自宅での診断の利便性が相まって、これらの製品に対する需要が高まっています。性感染症が蔓延し続ける中、より迅速で目立たずユーザーフレンドリーなオプションへのニーズが、自己検査市場のさらなる成長を促すと思われます。

さらに、数カ国の政府からの強力な支援や、業界の大手企業によるSTI用キット開発のための戦略的イニシアティブが、市場の成長を後押ししています。例えば、Burnet InstituteとAtomo Diagnosticsがオーストラリア政府から244万米ドルの資金援助を受け、活動性梅毒の迅速検査法を共同開発したことは、性感染症自己検査市場の主な市場促進要因となっています。指を刺す血液サンプルと梅毒抗体アッセイを使用するこのラテラルフロー検査は、専門家による検査と家庭での自己検査の両方のオプションを提供し、検査をより身近で便利で目立たないものにします。迅速で使いやすい診断技術におけるこのような技術革新は、キットの普及を加速させ、より迅速で信頼性の高いSTD検査ソリューションに対する需要を満たすことで、より広範な市場の成長を促進しています。

性感染症自己検査市場：分析概要

  • 2024年には、CT/NG検査分野が性感染症自己検査市場で最大の収益を生み出す分野となりました。これは、世界的にこれらの感染症の有病率が高いことに起因しています。クラミジアと淋病は、最もよく報告される性感染症のひとつであり、迅速でアクセスしやすい検査に対する大きな需要を牽引しています。
  • 使いやすく正確な診断ソリューションと相まって、これらの感染症に対する自己検査キットの採用が増加していることが、市場におけるCT/NG分野の優位性をさらに強固なものにしています。
  • HIV検査分野は、早期発見と予防に対する需要の高まりにより、予測期間中に最も急成長すると予想されます。HIVとその影響に関する意識の高まりに伴い、より多くの人々が自宅で目立たない便利なオプションを求めるようになっています。
  • また、迅速なHIV自己検査の進歩や政府の支援イニシアティブも、このセグメントの急成長に寄与しています。
  • 北米地域は、高度な医療インフラ、強力な啓発キャンペーン、簡便な家庭用検査ソリューションに対する消費者の需要の高まりにより、2024年には世界市場のトップに君臨すると見られています。同地域は早期発見に重点を置いており、規制当局の支援や技術革新と相まって、市場の主導権をさらに牽引しています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 性感染症自己検査市場：変動要因・傾向・範囲

  • 市場連関の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因の分析
  • 性感染症自己検査市場：分析ツール
    • 業界分析：ポーターのファイブフォース分析
    • PESTEL分析

第4章 性感染症自己検査市場：用途別の推定・動向分析

  • 性感染症自己検査市場：用途別のダッシュボード
  • 性感染症自己検査市場：用途別の変動分析
  • 性感染症自己検査市場：用途別 (収益ベース)
  • クラミジア・トラコマチス/淋菌 (CT/NG) 検査
  • 梅毒検査
  • HIV検査
  • その他

第5章 性感染症自己検査市場：地域別推定・動向分析

  • 地域ダッシュボード
  • 市場規模の予測と動向分析 (2018～2030年)
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 最新動向と影響分析：主要メーカー別
  • 企業/競合の分類
  • ベンダー情勢
    • 主要な流通業者・チャネルパートナーの一覧
    • 主要顧客
    • 主要企業の市場シェア分析 (2024年)
    • OraSure Technologies, Inc.
    • Selfdiagnostics
    • Wondfo
    • bioLytical Laboratories
    • autotest VIH
    • Abbott
    • Visby Medical
    • PrivaPath Diagnostics（LetsGetChecked）
    • NOWDiagnostics
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 4 Global STD Self Testing, by Region, 2018 - 2030 (USD Billion)
  • Table 5 North America STD Self Testing, by Country, 2018 - 2030 (USD Billion)
  • Table 6 North America STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 7 U.S. STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 8 Canada STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 9 Mexico STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 10 Europe STD Self Testing, by Country, 2018 - 2030 (USD Billion)
  • Table 11 Europe STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 12 Germany STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 13 UK STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 14 France STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 15 Italy STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 16 Spain STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 17 Denmark STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 18 Sweden STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 19 Norway STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 20 Asia Pacific STD Self Testing, by Country, 2018 - 2030 (USD Billion)
  • Table 21 Asia Pacific STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 22 China STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 23 Japan STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 24 India STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 25 South Korea STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 26 Australia STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 27 Thailand STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 28 Latin America STD Self Testing, by Country, 2018 - 2030 (USD Billion)
  • Table 29 Latin America STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 30 Brazil STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 31 Argentina STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 32 Middle East & Africa STD Self Testing, by Country, 2018 - 2030 (USD Billion)
  • Table 33 Middle East & Africa STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 34 South Africa STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 35 Saudi Arabia STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 36 UAE STD Self Testing, by Application, 2018 - 2030 (USD Billion)
  • Table 37 Kuwait STD Self Testing, by Application, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 STD Self Testing Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global STD Self Testing Market, for Application, 2018 - 2030 (USD Billion)
  • Fig. 16 Global STD Self Testing Market, for CT/NG Testing, 2018 - 2030 (USD Billion)
  • Fig. 17 Global STD Self Testing Market, for Syphilis Testing, 2018 - 2030 (USD Billion)
  • Fig. 18 Global STD Self Testing Market, for HIV Testing, 2018 - 2030 (USD Billion)
  • Fig. 19 Global STD Self Testing Market, for Others, 2018 - 2030 (USD Billion)
  • Fig. 20 Regional Marketplace: Key Takeaways
  • Fig. 21 Regional Outlook, 2024 & 2030
  • Fig. 22 Global STD Self Testing Market: Region Movement Analysis
  • Fig. 23 North America STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 24 U.S. STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 25 Canada STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 26 Mexico STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 27 Europe STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 28 Germany STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 29 UK STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 30 France STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 31 Italy STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 32 Spain STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 33 Denmark STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 34 Sweden STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 35 Norway STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 36 Asia Pacific STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 37 Japan STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 38 China STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 39 India STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 40 Australia STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 41 South Korea STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 42 Thailand STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 43 Latin America STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 44 Brazil STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 45 Argentina STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 46 Middle East and Africa STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 47 South Africa STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 48 Saudi Arabia STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 49 UAE STD Self Testing Market, 2018 - 2030 (USD Billion)
  • Fig. 50 Kuwait STD Self Testing Market, 2018 - 2030 (USD Billion)
目次
Product Code: GVR-4-68040-521-9

STD Self-Testing Market Growth & Trends:

The global STD self testing market size is expected to reach USD 1.98 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.75% from 2025 to 2030. The growing demand for privacy and convenience is a key driver for the STD self-testing market, as individuals seek more discreet and accessible ways to monitor their sexual health. Many people are hesitant to visit clinics due to the stigma associated with STDs and concerns about confidentiality, especially in smaller communities or regions with limited healthcare access. Self-test kits, which offer the convenience of being taken at home, allow users to test privately without the need for clinical visits. The ease of ordering tests online and receiving quick, reliable results has significantly contributed to adopting self-testing solutions, especially among younger populations who value autonomy and confidentiality in managing their health. This trend is expected to continue driving the market as individuals seek more personalized and hassle-free healthcare options.

In addition, the rising prevalence of STDs is expected to significantly drive the STD self-testing market, as increasing infection rates underscore the need for more accessible and efficient solutions. With cases of HIV, chlamydia, syphilis, and gonorrhea rising globally, public health systems are increasingly focused on early detection and prevention strategies. Self-testing kits offer a practical solution, enabling individuals to test in the privacy of their homes and seek treatment promptly. The growing awareness of the importance of regular STD testing, combined with the convenience of at-home diagnostics, is fueling demand for these products. As STDs continue to spread, the need for faster, discreet, and user-friendly options will drive further growth in the self-testing market.

Moreover, strong support from government of several countries and strategic initiatives undratken by industry's leading players to develop kits for STI's fuel the growth of the market. For instance, the collaboration between Burnet Institute and Atomo Diagnostics on the development of a rapid active syphilis test, backed by USD 2.44 million in funding from the Australian Government, highlights a key market driver for the STD self-testing market. This lateral flow test, which uses a finger prick blood sample and a syphilis antibody assay, offers both professional and at-home self-test options, making testing more accessible, convenient, and discreet. Such innovations in rapid and user-friendly diagnostic technologies are accelerating the adoption of kits, driving growth in the broader market by meeting the demand for quicker and more reliable STD test solutions.

STD Self-Testing Market Report Highlights:

  • In 2024, the CT/NG Testing segment was the largest revenue-generating sector of the STD self testing market. This is attributed to the high prevalence of these infections globally. Both Chlamydia and Gonorrhea are among the most commonly reported sexually transmitted infections, driving significant demand for rapid, accessible testing.
  • The increasing adoption of self-test kits for these infections, coupled with easy-to-use and accurate diagnostic solutions, further solidifies the dominance of the CT/NG segment in the market.
  • HIV Testing segment is expected to grow the fastest during the forecast period due to the rising demand for early detection and prevention. With increasing awareness about HIV and its impact, more people are seeking discreet, convenient options at home.
  • The advancement in rapid HIV self-tests and government-backed initiatives are also contributing to the segment's rapid growth, offering users quick, reliable results in a private setting.
  • The North American region is set to reign the global market in the year 2024 due to advanced healthcare infrastructure, strong awareness campaigns, and increasing consumer demand for convenient, at-home test solutions. The region's focus on early detection, coupled with regulatory support and innovation, further drives its market leadership.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. STD Self Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising STD prevalence
      • 3.2.1.2. Advancements in rapid diagnostic technology
      • 3.2.1.3. Supportive regulatory approvals & government initiatives
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Limited awareness and accessibility
  • 3.3. STD Self Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Social landscape
      • 3.3.2.5. Environmental landscape

Chapter 4. STD Self Testing Market: Application Estimates & Trend Analysis

  • 4.1. Global STD Self Testing Market: Application Dashboard
  • 4.2. Global STD Self Testing Market: Application Movement Analysis
  • 4.3. Global STD Self Testing Market by Application , Revenue
  • 4.4. CT/NG Testing
    • 4.4.1. CT/NG testing market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5. Syphilis Testing
    • 4.5.1. Syphilis testing market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.6. HIV Testing
    • 4.6.1. HIV testing market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. STD Self Testing Market: Regional Estimates & Trend Analysis by Application and End Use

  • 5.1. Regional Dashboard
  • 5.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.3. North America
    • 5.3.1. U.S.
      • 5.3.1.1. Key country dynamics
      • 5.3.1.2. Regulatory framework/ reimbursement structure
      • 5.3.1.3. Competitive scenario
      • 5.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.3.2. Canada
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Regulatory framework/ reimbursement structure
      • 5.3.2.3. Competitive scenario
      • 5.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.3.3. Mexico
      • 5.3.3.1. Key country dynamics
      • 5.3.3.2. Regulatory framework/ reimbursement structure
      • 5.3.3.3. Competitive scenario
      • 5.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Key country dynamics
      • 5.4.1.2. Regulatory framework/ reimbursement structure
      • 5.4.1.3. Competitive scenario
      • 5.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.2. Germany
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.3. France
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.4. Italy
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Regulatory framework/ reimbursement structure
      • 5.4.4.3. Competitive scenario
      • 5.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.5. Spain
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Regulatory framework/ reimbursement structure
      • 5.4.5.3. Competitive scenario
      • 5.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.6. Norway
      • 5.4.6.1. Key country dynamics
      • 5.4.6.2. Regulatory framework/ reimbursement structure
      • 5.4.6.3. Competitive scenario
      • 5.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.7. Sweden
      • 5.4.7.1. Key country dynamics
      • 5.4.7.2. Regulatory framework/ reimbursement structure
      • 5.4.7.3. Competitive scenario
      • 5.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.8. Denmark
      • 5.4.8.1. Key country dynamics
      • 5.4.8.2. Regulatory framework/ reimbursement structure
      • 5.4.8.3. Competitive scenario
      • 5.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/ reimbursement structure
      • 5.5.1.3. Competitive scenario
      • 5.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.5.2. China
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.5.3. India
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.5.4. Australia
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework/ reimbursement structure
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.5.5. South Korea
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Regulatory framework/ reimbursement structure
      • 5.5.5.3. Competitive scenario
      • 5.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.5.6. Thailand
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Regulatory framework/ reimbursement structure
      • 5.5.6.3. Competitive scenario
      • 5.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Key country dynamics
      • 5.6.1.2. Regulatory framework/ reimbursement structure
      • 5.6.1.3. Competitive scenario
      • 5.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.6.2. Argentina
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.7. MEA
    • 5.7.1. South Africa
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Regulatory framework/ reimbursement structure
      • 5.7.1.3. Competitive scenario
      • 5.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.7.3. UAE
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework/ reimbursement structure
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.7.4. Kuwait
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework/ reimbursement structure
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company market share analysis, 2024
    • 6.3.4. OraSure Technologies, Inc.
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Selfdiagnostics
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Wondfo
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. bioLytical Laboratories
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. autotest VIH
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Product benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. Abbott
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Product benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Visby Medical
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Product benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. PrivaPath Diagnostics (LetsGetChecked)
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Product benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. NOWDiagnostics
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Product benchmarking
      • 6.3.12.4. Strategic initiatives